Portable Bioprocessing Bioreactors Market Report 2026

Portable Bioprocessing Bioreactors Market Overview

• Portable Bioprocessing Bioreactors market size has reached to $2.8 billion in 2025 • Expected to grow to $5.03 billion in 2030 at a compound annual growth rate (CAGR) of 12.3% • Growth Driver: Growing Demand For Gene Therapies Fueling The Growth Of The Market Due To Advances In Genetic Sequencing • Market Trend: Innovative Portable Bioprocessing Systems Boost Scalability And Process Control • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Portable Bioprocessing Bioreactors Market?

Portable bioprocessing bioreactors are compact, mobile systems designed to facilitate controlled biological reactions and cell cultures outside traditional laboratory settings. They enable on-site bioprocessing with precise regulation of environmental conditions, enhancing flexibility and efficiency in research and production. The main product types of portable bioprocessing bioreactors are single-use bioreactors, stainless steel bioreactors, glass bioreactors, multi-use bioreactors, and smart bioreactors. Single-use bioreactors are disposable, pre-sterilized cultivation systems designed for single-use applications in bioprocessing, eliminating the need for cleaning and sterilization between batches. Their modes of operation include batch bioreactors, fed-batch bioreactors, continuous bioreactors, and perfusion bioreactors, and come in various capacities, such as 100 L–500 L, 50 L–100 L, 10 L–50 L, and 1 L–10 L. They serve multiple applications, including cell therapy and regenerative medicine, vaccine and biologic development, biopharmaceutical production, biologics and biosimilars manufacturing, and tissue engineering, and cater to a wide range of end-users such as academic and research institutions, biopharmaceutical companies, contract research organizations (CROs), food and beverage manufacturers, and chemical and petrochemical industries.

What Is The Portable Bioprocessing Bioreactors Market Growth Forecast?

The portable bioprocessing bioreactors market size is expected to see rapid growth in the next few years. It will grow to $5.03 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to advancements in single-use and smart bioreactor technologies, increasing investment in cell therapy and regenerative medicine, expansion of contract research organizations (cros), integration of ai-driven monitoring and process automation, rising demand for point-of-care and on-site bioprocessing solutions. Major trends in the forecast period include rising adoption of single-use and smart bioreactors, expansion of cell therapy and regenerative medicine applications, growth in vaccine and biologics development programs, increasing focus on biopharmaceutical production efficiency, integration of remote monitoring and data analytics in bioreactor operations.

Global Portable Bioprocessing Bioreactors Market Segmentation

1) By Product Type: Single-Use Bioreactors, Stainless Steel Bioreactors, Glass Bioreactors, Multi-Use Bioreactors, Smart Bioreactors 2) By Mode Of Operation: Batch Bioreactors, Fed-Batch Bioreactors, Continuous Bioreactors, Perfusion Bioreactors 3) By Capacity: 100L–500L, 50L–100L, 10L–50L, 1L–10L 4) By Application: Cell Therapy And Regenerative Medicine, Vaccine And Biologic Development, Biopharmaceutical Production, Biologics And Biosimilars Manufacturing, Tissue Engineering 5) By End-User: Academic And Research Institutions, Biopharmaceutical Companies, Contract Research Organizations (CROs), Food And Beverage Manufacturers, Chemical And Petrochemical Industries Subsegments: 1) By Single-Use Bioreactors: Disposable Bags, Stirred Tank, Rocking Motion, Fixed Bed, Wave Bioreactors 2) By Stainless Steel Bioreactors: Jacketed, Half Pipe, Coil, External, Internal 3) By Glass Bioreactors: Jacketed, Non-Jacketed, Double Jacketed 4) By Multi-Use Bioreactors: Airlift, Bubble Column 5) By Smart Bioreactors: Automated Control, Sensor Integrated, Remote Monitoring, Data Analytics Enabled

What Is The Driver Of The Portable Bioprocessing Bioreactors Market?

The growing demand for gene therapies is expected to propel the growth of the portable bioprocessing bioreactors market going forward. Gene therapy refers to a medical technique that involves modifying or replacing defective genes to treat or prevent diseases. The increasing demand for gene therapy is due to advancements in genetic sequencing and diagnostics, which enable precise identification of disease-causing genes for targeted treatment. Portable bioprocessing bioreactors accelerate gene therapies by enabling on-site, flexible manufacturing with scalable and controlled environments. They reduce processing time and complexity, improving the speed and efficiency of producing personalized treatments. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved six gene therapy products in 2023, up from five approvals in 2022. Therefore, the growing demand for gene therapies is driving the growth of the portable bioprocessing bioreactors industry.

Key Players In The Global Portable Bioprocessing Bioreactors Market

Major companies operating in the portable bioprocessing bioreactors market are Thermo Fisher Scientific Inc., Merck KGaA, Cytiva Bioscience Holding Ltd., Sartorius AG, PBS Biotech Inc., Culture Biosciences Inc., FermEx Inc.

Global Portable Bioprocessing Bioreactors Market Trends and Insights

Major companies operating in the portable bioprocessing bioreactors market are focusing on developing technologically advanced products, such as single-use bioreactors, to enhance flexibility and streamline cell therapy manufacturing. Single-use bioreactors are disposable systems using pre-sterilized plastic bags instead of reusable vessels, allowing faster setup, reduced contamination, and lower cleaning costs in biomanufacturing. For instance, in April 2025, Thermo Fisher Scientific, a US-based biotechnology company, launched the 5L DynaDrive single-use bioreactor, a cutting-edge portable bioprocessing system designed to improve scalability and process control for cell culture applications. This bioreactor enables seamless scaling from 1 to 5,000 liters while maintaining consistent reactor design and film quality, resulting in a 27% boost in productivity compared to conventional glass bioreactors. It boasts a compact, user-friendly benchtop design and incorporates biobased films along with BioTitan retention devices to reduce product loss and promote sustainability.

What Are Latest Mergers And Acquisitions In The Portable Bioprocessing Bioreactors Market?

In June 2023, Donaldson Company Inc., a U.S.-based filtration and materials technology company, acquired Univercells Technologies S.A., based in Belgium, for €136 million. With this acquisition, Donaldson Company, Inc. aims to broaden its life sciences business by integrating Univercells Technologies S.A.’s biomanufacturing platforms, including its scale‑X single-use bioreactor and NevoLine Upstream system, to offer end-to-end solutions for viral vector production. Univercells Technologies S.A. is a Belgium‑based company that specializes in cost-effective biomanufacturing technologies for cell and gene therapy, vaccines, and advanced therapeutics.

Regional Insights

North America was the largest region in the portable bioprocessing bioreactors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Portable Bioprocessing Bioreactors Market?

The portable bioprocessing bioreactors market consists of sales of hollow fiber bioreactors, fixed bed bioreactors, air-lift bioreactors, and wave-mixed bioreactors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Portable Bioprocessing Bioreactors Market Report 2026?

The portable bioprocessing bioreactors market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the portable bioprocessing bioreactors industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.